KMI
67
4
BXP
55
-4
FTI
84
2
CMG
69
-3
ORCL
58
3
HP
52
2
AA
61
5
BF.B
37
2
ED
53
-2
APA
30
3
MLM
58
4
EMN
59
3
TXN
45
2
OI
38
-4
SBUX
52
13
TGT
31
4
WFC
80
-2
TXT
55
2
ALLE
39
-2
ECL
62
2
KMI
67
4
BXP
55
-4
FTI
84
2
CMG
69
-3
ORCL
58
3
HP
52
2
AA
61
5
BF.B
37
2
ED
53
-2
APA
30
3
MLM
58
4
EMN
59
3
TXN
45
2
OI
38
-4
SBUX
52
13
TGT
31
4
WFC
80
-2
TXT
55
2
ALLE
39
-2
ECL
62
2
Financhill
Back

WuXi Biologics (Cayman) 10K Form

Sell
32

WXXWY
WuXi Biologics (Cayman)

Last Price:
4.00
Seasonality Move:
-3.04%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive WXXWY News And Ratings

See the #1 stock for the next 7 days that we like better than WXXWY

WXXWY Financial Statistics

Sales & Book Value

Annual Sales: $2.41B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $2.69
Price / Book: 1.38

Profitability

EPS (TTM): 0.16680
Net Income (TTM): $365.83M
Gross Margin: $965.27M
Return on Equity: 6.19%
Return on Assets: 4.8%

WuXi Biologics (Cayman) Earnings Forecast

Key WuXi Biologics (Cayman) Financial Ratios

  • The Gross Profit Margin over the past 10 years for WXXWY is 40.08%.
  • The Selling, General & Administrative Expenses for WXXWY have been equal to 10.50% of Gross Profit Margin.
  • The Research & Development expenses have been 4.61% of Revenue.
  • The Interest Expense is 4.66% of Operating Income.
  • The Net Earning history of WXXWY is 19.96% of Total Revenues.
  • Per Share Earnings over the last 10 years have been positive in 8 years.

WuXi Biologics (Cayman) Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: WXXWY
Website: wuxibiologics.com

Debt

Debt-to-Equity Ratio: 0.05
Current Ratio: 2.91
Quick Ratio: 2.4

Price-to-Earnings

Trailing P/E Ratio: 17.27
Forward P/E Ratio: 0

WXXWY Technical Analysis vs Fundamental Analysis

Sell
32
WuXi Biologics (Cayman) (WXXWY) is a Sell

Is WuXi Biologics (Cayman) a Buy or a Sell?